Boston, MA With preliminary results from a study in Botswana, Harvard School of Public Health researchers have found that people with HIV-1 subtype C in resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve comparable results to those in the developed world. A fully supported health care delivery system and infrastructure help ensure this success, according to data published in November 2005 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS).

More than 95 percent of HIV-infected people live in resource-poor nations -- and only a fraction of the people have access to the potentially lifesaving treatment. This study evaluated the effectiveness of combination ARV treatment in decreasing HIV disease and death. With more than one year of follow-up for clinical and laboratory outcomes and two years of follow-up for survival estimates, the majority of enrolled patients on ARV treatment experienced favorable clinical outcomes, including improved CD4 counts, decreased viral load and weight gain comparable with other successful care and treatment programs in the developed world.

"This data confirms what we are starting to see throughout the developing world. Patients will do fine regardless of social and economic status, provided the necessary infrastructure and funding are in place," said Richard Marlink, M.D., senior author of the article and professor in the Department of Immunology and Infectious Diseases at Harvard School of Public Health (HSPH).

The clinical data was collected from a public-private partnership between the Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education (BHP) and the Infectious Disease Care Clinic (IDCC) at Princess Marina Hospital and funded through Bristol-Myers Squibbs' Secure the Future initiative. Initiated in April 2001, this public sector treatment program led to the development of the Botswana's national pro
'"/>

Contact: Robin Herman
rherman@hsph.harvard.edu
617-432-4752
Harvard School of Public Health
4-Nov-2005

Page: 1 2
Related medicine news :

1. Editorial: Pay more attention to genital herpes infections in HIV-infected persons
2. New study shows benefit of early therapy in HIV-infected infants
3. Low-cost drug gaining favor for use in HIV-infected children in poor countries
4. Autoimmune overload may damage HIV-infected brain
5. Asymptomatic HIV-infected newborns may benefit from early drug treatment, Stanford study shows
6. New guidelines recommend screening HIV-infected patients for kidney disease
7. Grandparents, older adults encouraged to seek help for a sleep disorder
8. States taking action to insure nations 13.3M uninsured young adults
9. Predicting the quality of life for older adults
10. New study demonstrates that Lubiprostone may improve symptom relief rates in adults with IBS-C
11. Teens can perform CPR as well as adults and should be taught from an early age